P. Hauck

A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN

R. Lipton, J. Krege, Simin K. Baygani, 2021, The Journal of Headache and Pain.

Qualitative effect of fenofibrate and quantitative effect of atorvastatin on LDL profile in combined hyperlipidemia with dense LDL.

W. März, M. Baumstark, H. Wieland, 2004, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes

M. Mintun, M. Pontecorvo, P. Hauck, 2022, JAMA neurology.

Lasmiditan in patients with common migraine comorbidities: a post hoc efficacy and safety analysis of two phase 3 randomized clinical trials

Simin K. Baygani, P. Hauck, D. Clemow, 2020, Current medical research and opinion.

Tolerability and Safety of Lasmiditan Treatment in Elderly Patients With Migraine: Post Hoc Analyses From Randomized Studies.

H. Hochstetler, Simin K. Baygani, P. Hauck, 2021, Clinical therapeutics.

Functional restoration with reyvow (FREE): A US-based cross-sectional survey in patients taking lasmiditan

Kayla M Mills, P. Hauck, T. Schwedt, 2021, Journal of Neurological Sciences.

APOE ε4's impact on response to amyloid therapies in early symptomatic Alzheimer's disease: Analyses from multiple clinical trials.

M. Mintun, P. Hauck, J. Sparks, 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.

The Association Between the Occurrence of Common Treatment-Emergent Adverse Events and Efficacy Outcomes After Lasmiditan Treatment of a Single Migraine Attack: Secondary Analyses from Four Pooled Randomized Clinical Trials

A. Hake, J. Krege, P. Hauck, 2022, CNS Drugs.

Effect of a change in lasmiditan dose on efficacy and safety in patients with migraine

H. Hochstetler, M. Peres, P. Hauck, 2021, Postgraduate medicine.